Find disease awareness content and relevant supporting materials

Omeros Corporation announced that the results of four real-world clinical studies evaluating the benefits of Omidria (phenylephrine and ketorolac intraocular...

Discover the latest clinical guidelines from the German Society of Neurology on managing complex neuropsychiatric conditions in Parkinson’s disease. This comprehensive update covers evidence-based strategies for diagnosing and treating impulse control disorders, psychosis, and delirium, offering crucial insights for optimizing patient care.

We aim to describe the burden of disease in MG including sociodemographic, economical, psychosocial as well as clinical aspects, to compare health-related quality of life (HRQoL) of patients with MG to the general population (genP) and to explore risk factors for a lower HRQoL.

A series of articles published recently by The BMJ explore this issue, examining the social, legal and ethical considerations that have to be made before assisted dying can be brought into law.

Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder caused by the deposition of abnormal proteins in neurons of the basal ganglia that limit motor ability, resulting in disability and reduced quality...

Discover the latest advancements in Parkinson’s disease care with the 2023 German Society of Neurology guidelines. These new recommendations expand on international standards, introducing innovative care concepts like PD day clinics and networks.

The burden of herpes zoster (HZ) is significant worldwide, with millions affected and the incidence rising. Current literature has identified some risk factors for this disease; however, there is yet to be a comprehensive study that pools all evidence to provide estimates of risk.

Merck KGaA, a leading science and technology company, announced the launch of two innovative fertility technologies, Gavi oocyte protocol and...

The FDA has cleared the Senhance System, a new robotically-assisted surgical device (RASD) that can help facilitate minimally invasive surgery.The...

Background: Spinal muscular atrophy is an autosomal recessive neuromuscular disorder that is caused by an insufficient level of survival motor neuron (SMN) protein. Nusinersen is an antisense oligonucleotide drug that modifies...